|
Market Closed -
Nasdaq
16:00:00 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 12.06 USD | +1.94% |
|
+11.25% | +56.62% |
| 08-12 | B. Riley Adjusts Fennec Pharmaceuticals Price Target to $18 From $16, Maintains Buy Rating | MT |
| 08-11 | Fennec Pharmaceuticals at Multi-Year High After Swing to Q2 Earnings Beat | MT |
| Market Cap | 423M 366M 343M 313M 589M 40.32B 598M 4.04B 1.58B 20.19B 1.59B 1.55B 67.34B | P/E 2026 * |
37.4x | P/E 2027 * | 12.2x |
|---|---|---|---|---|---|
| Enterprise Value | 423M 366M 343M 313M 589M 40.32B 598M 4.04B 1.58B 20.19B 1.59B 1.55B 67.34B | EV / Sales 2026 * |
5.8x | EV / Sales 2027 * | 4.1x |
| Free-Float |
79.54% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Fennec Pharmaceuticals Inc.
| 1 day | +1.94% | ||
| 1 week | +11.25% | ||
| Current month | +26.02% | ||
| 1 month | +12.19% | ||
| 3 months | +78.14% | ||
| 6 months | +43.23% | ||
| Current year | +56.62% |
| 1 week | 10.76 |  | 13.25 |
| 1 month | 9.4 | | 13.25 |
| Current year | 5.65 | | 13.25 |
| 1 year | 5.65 | | 13.25 |
| 3 years | 3.96 | | 13.25 |
| 5 years | 3.82 | | 13.25 |
| 10 years | 1.64 | | 14.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jeffrey Hackman
CEO | Chief Executive Officer | 64 | 2024-08-15 |
Robert Andrade
DFI | Director of Finance/CFO | 51 | 2010-01-05 |
Pierre Sayad
CTO | Chief Tech/Sci/R&D Officer | 51 | 2024-10-27 |
| Director | Title | Age | Since |
|---|---|---|---|
Chris Rallis
BRD | Director/Board Member | 72 | 2011-08-24 |
Khalid Islam
CHM | Chairman | 69 | 2015-12-08 |
Marco Brughera
BRD | Director/Board Member | 70 | 2016-08-09 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/3/26 | Buy | Chief Technology Officer | 168 | 0.0005% | ||
| 8/3/26 | Buy | Executive/Senior Manager | 168 | 0.0005% | ||
| 8/3/26 | Sell | -10,000 | 0.0288% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.94% | +11.25% | +32.38% | +42.05% | 414M | |
| -0.92% | +1.43% | +83.05% | +128.86% | 1,088B | |
| +0.47% | +1.98% | +50.26% | +50.75% | 629B | |
| +0.83% | +2.85% | +24.49% | +64.82% | 440B | |
| -0.88% | -0.66% | +45.09% | +36.64% | 359B | |
| -0.37% | -1.15% | +26.89% | +36.31% | 291B | |
| +0.05% | -1.20% | +2.31% | +6.15% | 245B | |
| +0.40% | +3.21% | +44.42% | +59.17% | 225B | |
| -0.42% | +1.58% | -8.48% | -51.94% | 204B | |
| +1.67% | +5.56% | +14.98% | +72.68% | 168B | |
| Average | +0.28% | +2.61% | +31.54% | +44.55% | 364.96B | |
| Weighted average by Cap. | -0.13% | +1.47% | +46.05% | +65.96% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 72.9M 63.19M 59.24M 54.01M 102M 6.96B 103M 697M 272M 3.48B 274M 268M 11.62B | 103M 89.41M 83.82M 76.43M 144M 9.84B 146M 987M 385M 4.93B 387M 379M 16.44B |
| Net income | 11.25M 9.75M 9.14M 8.33M 15.68M 1.07B 15.93M 108M 42.01M 537M 42.22M 41.31M 1.79B | 35.24M 30.54M 28.63M 26.11M 49.12M 3.36B 49.91M 337M 132M 1.68B 132M 129M 5.62B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-13 | US$12.06 | +1.94% | 191,016 |
| 26-08-12 | US$11.83 | -7.43% | 358,942 |
| 26-08-11 | US$12.78 | +16.82% | 720,034 |
| 26-08-10 | US$10.94 | -5.49% | 312,109 |
| 26-08-07 | US$11.58 | +6.78% | 226,652 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- FENC Stock
Select your edition
All financial news and data tailored to specific country editions
